BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 969 filers reported holding BAXTER INTL INC in Q3 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $245,000 | -28.4% | 3,719 | -16.2% | 0.05% | -29.2% |
| Q3 2018 | $342,000 | +4.3% | 4,438 | 0.0% | 0.07% | -5.3% |
| Q2 2018 | $328,000 | -3.5% | 4,438 | -15.2% | 0.08% | -3.8% |
| Q1 2018 | $340,000 | -38.6% | 5,231 | -38.9% | 0.08% | -41.9% |
| Q4 2017 | $554,000 | +4.5% | 8,560 | +1.3% | 0.14% | -73.2% |
| Q3 2017 | $530,000 | -10.3% | 8,447 | -13.5% | 0.51% | -11.8% |
| Q2 2017 | $591,000 | -27.6% | 9,769 | -38.0% | 0.58% | -31.4% |
| Q1 2017 | $816,000 | -27.3% | 15,750 | -37.7% | 0.84% | -38.5% |
| Q4 2016 | $1,122,000 | -20.4% | 25,290 | -14.6% | 1.36% | -9.6% |
| Q3 2016 | $1,410,000 | -9.6% | 29,602 | -14.1% | 1.51% | -2.0% |
| Q2 2016 | $1,559,000 | -5.6% | 34,471 | -14.3% | 1.54% | -7.1% |
| Q1 2016 | $1,652,000 | +1.8% | 40,213 | -5.4% | 1.66% | -15.5% |
| Q4 2015 | $1,622,000 | +15.9% | 42,505 | -0.3% | 1.96% | +2.2% |
| Q3 2015 | $1,400,000 | -47.9% | 42,623 | +10.9% | 1.92% | -50.9% |
| Q2 2015 | $2,688,000 | +5.4% | 38,427 | +3.2% | 3.90% | -3.4% |
| Q1 2015 | $2,551,000 | +29.4% | 37,236 | +38.4% | 4.04% | -13.0% |
| Q4 2014 | $1,972,000 | +97.4% | 26,904 | +93.2% | 4.64% | -2.2% |
| Q3 2014 | $999,000 | +79.7% | 13,922 | +81.2% | 4.75% | +2.5% |
| Q2 2014 | $556,000 | +0.4% | 7,685 | +2.1% | 4.63% | -4.4% |
| Q1 2014 | $554,000 | +14.5% | 7,524 | +8.2% | 4.84% | +17.8% |
| Q4 2013 | $484,000 | +26.4% | 6,957 | +19.4% | 4.11% | +7.3% |
| Q3 2013 | $383,000 | – | 5,827 | – | 3.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |